A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy

Clinical trial NCT04362761 · COMPLETED

Trial details

NCT number: NCT04362761
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2020-05-04
Primary completion: 2022-12-21
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.